Skip to main content
. 2019 Aug 21;9(8):e028855. doi: 10.1136/bmjopen-2018-028855

Table 3.

Meta-analytical outputs for the safety of PVP compared with TURP

Outcomes No of studies Sample size Heterogeneity (total) MD or RR (95% CI) Test for overall effect
PVP TURP χ2 df I2 (%) P value
Z P value
Operation time 14 979 870 216.27 13 94 <0.01 15.24 (8.91 to 21.54) 4.72 <0.01
6* 429* 428* 6.01* 5* 17* 0.31* 10.60 (8.39 to 12.81)* 9.40* <0.01*
Hospitalisation time 11 819 723 600.62 10 98 <0.01 −1.98 (−2.56 to −1.39) 6.59 <0.01
3* 240* 229* 6.29* 2* 68* <0.01* −1.83 (−2.25 to −1.40)* 8.42* <0.01*
Catheterisation time 14 861 794 964.75 13 99 <0.01 −1.25 (−1.58 to −0.92) 7.48 <0.01
Blood loss 6 389 335 46.05 5 89 <0.01 −1.33 (−2.05 to −0.61) 3.62 <0.01
Transfusion 14 1110 946 10.87 13 0 0.62 0.14 (0.08 to 0.26) 6.10 <0.01
TUR syndrome 7 590 435 0.73 6 0 0.99 0.19 (0.06 to 0.61) 2.82 <0.01
Capsular perforation 7 641 451 1.84 6 0 0.93 0.09 (0.03 to 0.26) 4.51 <0.01
Clot retention 8 699 504 1.72 7 0 0.97 0.14 (0.07 to 0.29) 5.32 <0.01
Urinary tract infection 13 1049 860 8.79 12 0 0.72 1.15 (0.85 to 1.55) 0.89 0.38
Acute urinary retention 10 694 653 5.55 9 0 0.78 1.19 (0.80 to 1.75) 0.86 0.39
Urinary incontinence 4 296 263 4.28 3 30 0.23 1.45 (0.74 to 2.86) 1.08 0.28
Bladder neck contracture 8 523 520 4.32 7 0 0.74 1.05 (0.57 to 1.94) 0.16 0.87
Urethral stricture 15 1172 980 9.37 14 0 0.81 0.81 (0.57 to 1.16) 1.14 0.25
Retrograde ejaculation 4 320 314 15.06 3 80 <0.01 0.72 (0.49 to 1.07) 1.62 0.11
Dysuria 12 1079 854 24.80 11 58 0.01 1.76 (1.17 to 2.65) 2.71 <0.01
Reintervention 12 980 809 14.58 11 25 0.20 1.81 (1.28 to 2.56) 3.35 <0.01

*Using sensitivity analysis.

MD, mean difference; PVP, photoselective vaporisation of the prostate; RR, risk ratio; TR, syndrome=transurethral resection syndrome; TURP, transurethral resection of the prostate.